Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Gargini

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Redox Biology|January 10, 2020
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomasMaribel Escoll, Diego Lastra, Marta Pajares, et al.
Neuro-Oncology|February 27, 2024
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastomaSara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, et al.
Oxidative Medicine and Cellular Longevity|August 31, 2019
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in GlioblastomaEsther Hernández-SanMiguel, Ricardo Gargini, Teresa Cejalvo, et al.
Neuro-Oncology Advances|November 3, 2022
On optimal temozolomide scheduling for slowly growing glioblastomasBerta Segura-Collar, Juan Jiménez-Sánchez, Ricardo Gargini, et al.
Acta Neuropathologica|May 2, 2021
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's diseaseVega García-Escudero, Daniel Ruiz-Gabarre, Ricardo Gargini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 31, 2022
IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in GlioblastomasRicardo Gargini, Berta Segura-Collar, María Garranzo-Asensio, et al.
Cancer Immunology Research|April 10, 2025
The TRIB2-DNMT1 pathway generates an immune cold microenvironment in glioblastoma and its inhibition promotes immunotherapyBerta Segura-Collar, Blanca Cómitre-Mariano, Denisse Alcivar López, et al.
Theranostics|January 2, 2025
S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architectureBlanca Cómitre-Mariano, Berta Segura-Collar, Gabriel Vellila-Alonso, et al.
Ebiomedicine|June 28, 2025
Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasionBerta Segura-Collar, Lucia Mondejar-Ruescas, Denisse Alcivar-López, et al.
Cancer Research|February 17, 2021
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of GliomasBerta Segura-Collar, María Garranzo-Asensio, Beatriz Herranz, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Redox Biology|January 10, 2020
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomasMaribel Escoll, Diego Lastra, Marta Pajares, et al.
Neuro-Oncology|February 27, 2024
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastomaSara Hiller-Vallina, Lucia Mondejar-Ruescas, Marta Caamaño-Moreno, et al.
Oxidative Medicine and Cellular Longevity|August 31, 2019
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in GlioblastomaEsther Hernández-SanMiguel, Ricardo Gargini, Teresa Cejalvo, et al.
Neuro-Oncology Advances|November 3, 2022
On optimal temozolomide scheduling for slowly growing glioblastomasBerta Segura-Collar, Juan Jiménez-Sánchez, Ricardo Gargini, et al.
Acta Neuropathologica|May 2, 2021
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's diseaseVega García-Escudero, Daniel Ruiz-Gabarre, Ricardo Gargini, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 31, 2022
IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in GlioblastomasRicardo Gargini, Berta Segura-Collar, María Garranzo-Asensio, et al.
Cancer Immunology Research|April 10, 2025
The TRIB2-DNMT1 pathway generates an immune cold microenvironment in glioblastoma and its inhibition promotes immunotherapyBerta Segura-Collar, Blanca Cómitre-Mariano, Denisse Alcivar López, et al.
Theranostics|January 2, 2025
S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architectureBlanca Cómitre-Mariano, Berta Segura-Collar, Gabriel Vellila-Alonso, et al.
Ebiomedicine|June 28, 2025
Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasionBerta Segura-Collar, Lucia Mondejar-Ruescas, Denisse Alcivar-López, et al.
Cancer Research|February 17, 2021
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of GliomasBerta Segura-Collar, María Garranzo-Asensio, Beatriz Herranz, et al.
Pageof 5